Results 141 to 150 of about 108,380,509 (205)

Potential risk of neoplasms with fezolinetant: clinical evidence, mechanisms, and post-marketing implications. [PDF]

J Endocr Soc
Boretti E, Dogné JM, Douxfils J.
europepmc   +1 more source

Elinzanetant: Defining the Role of Dual Neurokinin-1 and Neurokinin-3 Receptor Antagonism for Management of Vasomotor Symptoms in Menopause. [PDF]

J Menopausal Med
Teli V, Teli A.
europepmc   +1 more source

Refractory nausea in an 86-year-old patient after surgery. [PDF]

CMAJ
Bhattacharjee A, Gruber A, MacMillan TE, Shah R.   +3 more
europepmc   +1 more source

Postoperative nausea and vomiting: current concepts, management strategies, and future perspectives. [PDF]

Front Pharmacol
Qiu L, Alhaskawi A, Abdo Moqbel SA, Yuan H.   +3 more
europepmc   +1 more source

NK2R signaling governs intestinal lipid mobilization and mucosal inflammation. [PDF]

Elife
Perez PA, Liu CC, Ferrari A, Littlejohn NK, Kennelly JP, Robinson EM, Nguyen-Tran VTB, Athanacio J, Joesph SB, Amso Z, Tontonoz P, Srinivasan S.   +11 more
europepmc   +1 more source

Efficacy of steroid-omitting antiemetic therapy in patients with advanced pancreatic cancer receiving nano-liposomal irinotecan plus fluorouracil and leucovorin. [PDF]

Support Care Cancer
Tokito Y, Ishigaki K, Nara K, Endo G, Nishio H, Fukuda K, Suzuki T, Sato Y, Takahara N, Boku N, Fujishiro M.   +10 more
europepmc   +1 more source

Perioperative substance P/NK1R pharmacology: from PONV control to a testable cancer neuro-immune hypothesis. [PDF]

Front Immunol
Zhao J, Liu Z, Wang J.
europepmc   +1 more source

Efficacy and safety of GS1-144, a novel neurokinin 3 receptor antagonist, for moderate-to-severe vasomotor symptoms associated with menopause in Chinese women: a randomized, double-blind, placebo-controlled phase 2 trial. [PDF]

Menopause
Wang Y, Wang X, Wang W, Lin J, He Y, Chen H, Shou H, Ai X, Zhang Q, Cai Y, Wu Y, Guo R, Hu L, Chen H, Xiang W, Pan C, Yu Q.   +16 more
europepmc   +1 more source

Antiemetic-associated QT prolongation: a clinical review and risk-stratified prescribing framework for long QT syndrome. [PDF]

Eur Heart J Cardiovasc Pharmacother
Moustafa AT, Dabash O, Panigrahi PK, Khan HR.   +3 more
europepmc   +1 more source

Targeting Peptidergic Systems for Melanoma Treatment. [PDF]

Cancers (Basel)
Sánchez ML, Mehboob R, Coveñas R.
europepmc   +1 more source